McBarron Paul 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Jan 29, 2013
Insider Transaction Report
Form 4
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
- Award
Common Stock, $0.001 par value per share
2013-01-25+20,000→ 68,721 total - Award
Common Stock, $0.001 par value per share
2013-01-25+6,712→ 75,433 total
Footnotes (3)
- [F1]These securities were issued as part of the Issuer's annual equity compensation to executive officers under the Issuer's Amended and Restated 2006 Equity Incentive Plan.
- [F2]Of the shares of common stock reported, 30,714 shares are represented by unvested restricted stock units.
- [F3]Of the shares of common stock reported, 20,000 are represented by restricted stock units which will vest upon the fulfillment of certain clinical and financial conditions and terminate if they have not vested by December 31, 2014.